Published in Eur J Immunol on June 01, 2010
DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol (2011) 1.42
Kinetics of antigen expression and epitope presentation during virus infection. PLoS Pathog (2013) 1.21
MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA. Proc Natl Acad Sci U S A (2012) 1.02
Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters. Proc Natl Acad Sci U S A (2012) 1.01
TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells. Int Rev Immunol (2011) 0.87
A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice. Eur J Immunol (2014) 0.82
Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr virus infection with TCR-like antibodies. Sci Rep (2013) 0.78
Nucleocytoplasmic shuttling and CRM1-dependent MHC class I peptide presentation of human cytomegalovirus pp65. Med Microbiol Immunol (2012) 0.77
Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities. Blood (2016) 0.75
Antigen-specific single B cell sorting and expression-cloning from immunoglobulin humanized rats: a rapid and versatile method for the generation of high affinity and discriminative human monoclonal antibodies. BMC Biotechnol (2017) 0.75
Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late. J Immunol (2016) 0.75
Opportunities and challenges for TCR mimic antibodies in cancer therapy. Expert Opin Biol Ther (2016) 0.75
Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity (2008) 3.94
The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med (2007) 2.37
Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease. Clin Infect Dis (2006) 1.92
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Blood (2010) 1.55
Global genetic diversity of human metapneumovirus fusion gene. Emerg Infect Dis (2004) 1.53
Antibody-mediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes. Cancer Immunol Immunother (2005) 1.51
RNA binding targets aminoacyl-tRNA synthetases to translating ribosomes. J Biol Chem (2011) 1.41
The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. Immunity (2008) 1.30
Targeting the function of IFN-gamma-inducible protein 10 suppresses ongoing adjuvant arthritis. J Immunol (2002) 1.27
Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. J Clin Invest (2002) 1.14
Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells. Cancer Res (2004) 1.07
Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments. Eur J Immunol (2004) 1.04
Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity. Proc Natl Acad Sci U S A (2002) 1.03
Sole pathogen in acute bronchiolitis: is there a role for other organisms apart from respiratory syncytial virus? Pediatr Infect Dis J (2010) 1.02
Plasmid DNA encoding IFN-gamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis. J Immunol (2002) 1.02
The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res (2006) 1.01
T-cell-receptor-like antibodies - generation, function and applications. Expert Rev Mol Med (2012) 1.00
Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation. Autoimmun Rev (2005) 0.97
Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. J Immunol (2008) 0.97
Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions. J Mol Recognit (2003) 0.97
T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy. Expert Rev Anticancer Ther (2005) 0.96
Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J Clin Invest (2002) 0.95
Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts. Cancer Res (2008) 0.95
Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming. Proc Natl Acad Sci U S A (2012) 0.93
Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies. Eur J Immunol (2008) 0.93
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis. J Immunol (2014) 0.91
Late cytomegalovirus disease following liver transplantation. Transpl Int (2003) 0.91
A two-state electronic antigen and an antibody selected to discriminate between these states. Nano Lett (2008) 0.90
Vascular endothelial cells have impaired capacity to present immunodominant, antigenic peptides: a mechanism of cell type-specific immune escape. J Immunol (2005) 0.88
Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules. Eur J Immunol (2008) 0.88
Predicting and controlling the reactivity of immune cell populations against cancer. Mol Syst Biol (2009) 0.88
Targeted overexpression of IL-18 binding protein at the central nervous system overrides flexibility in functional polarization of antigen-specific Th2 cells. J Immunol (2005) 0.88
Mitigation of Lethal Radiation Syndrome in Mice by Intramuscular Injection of 3D Cultured Adherent Human Placental Stromal Cells. PLoS One (2013) 0.88
Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cells. Eur J Immunol (2004) 0.86
Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes. J Immunol (2003) 0.86
Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo. Proc Natl Acad Sci U S A (2004) 0.86
Development of a serological assay based on a synthetic peptide selected from the VP0 capsid protein for detection of human parechoviruses. J Clin Microbiol (2007) 0.85
Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen. J Immunol (2003) 0.85
Therapeutic antibodies: Discovery and development using the ProteOn XPR36 biosensor interaction array system. Anal Biochem (2010) 0.85
Human parechovirus type 3 central nervous system infections in Israeli infants. J Clin Virol (2013) 0.84
Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition. Cancer Res (2008) 0.84
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells. Cancer Res (2013) 0.84
Insight into the intrinsic sensitivity of the PCR assay used to detect CMV infection in amniotic fluid specimens. J Clin Virol (2004) 0.83
Antigen-dependent integration of opposing proximal TCR-signaling cascades determines the functional fate of T lymphocytes. J Immunol (2014) 0.83
Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies. J Immunol (2002) 0.83
Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope. J Autoimmun (2013) 0.83
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes. Eur J Immunol (2011) 0.82
Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming. Int Immunol (2006) 0.81
Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma. Anticancer Res (2009) 0.80
A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells. Cancer Immunol Immunother (2002) 0.79
Antibody molecules discriminate between crystalline facets of a gallium arsenide semiconductor. Nano Lett (2006) 0.79
Antibodies and their fragments as anti-cancer agents. Curr Pharm Des (2006) 0.78
Probing ATP-dependent conformational changes in the multidrug resistance protein 1 (MRP1/ABCC1) in live tumor cells with a novel recombinant single-chain Fv antibody targeted to the extracellular N-terminus. Int J Cancer (2005) 0.78
Targeting an extracellular epitope of the human multidrug resistance protein 1 (MRP1) in malignant cells with a novel recombinant single chain Fv antibody. Int J Cancer (2004) 0.78
Phage display of single-chain antibody constructs. Curr Protoc Immunol (2002) 0.78
Simultaneous monitoring of binding to and activation of tumor-specific T lymphocytes by peptide-MHC. J Immunol Methods (2003) 0.78
On the limited recognition of inorganic surfaces by short peptides compared with antibodies. J Pept Sci (2014) 0.77
Selective antibody-mediated targeting of class I MHC to EGFR-expressing tumor cells induces potent antitumor CTL activity in vitro and in vivo. Int J Cancer (2007) 0.77
Enteroviruses and sudden deafness. CMAJ (2003) 0.77
Mixed alkanethiol monolayers on submicrometric gold patterns: a controlled platform for studying cell-ligand interactions. Nano Lett (2012) 0.77
Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice. Cancer Immunol Immunother (2006) 0.77
Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation. J Clin Virol (2013) 0.76
Generation of recombinant immunotoxins for specific targeting of tumor-related peptides presented by MHC molecules. Methods Mol Biol (2003) 0.76
[Fertility treatment options for discordant couples living with HIV]. Harefuah (2013) 0.76
CMV-related thrombocytopenia treated with foscarnet: a case series and review of the literature. Platelets (2010) 0.76
A novel postpriming regulatory check point of effector/memory T cells dictated through antigen density threshold-dependent anergy. J Immunol (2007) 0.76
Disruption of P-glycoprotein anticancer drug efflux activity by a small recombinant single-chain Fv antibody fragment targeted to an extracellular epitope. Int J Cancer (2004) 0.76
A multifaceted 'omics' approach for addressing the challenge of antimicrobial resistance. Future Microbiol (2015) 0.76
Antibody response to influenza vaccine in pediatric liver transplant recipients. Pediatr Infect Dis J (2011) 0.75
Changes in thyroid function in Ethiopian and non-Ethiopian Israeli patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome. Endocr Pract (2012) 0.75
Electrically controlled molecular recognition harnessed to activate a cellular response. Nano Lett (2011) 0.75
Recombinant single-chain and disulfide-stabilized Fv immunotoxins for cancer therapy. Methods Mol Biol (2003) 0.75
Melanoma cells present high levels of HLA-A2-tyrosinase in association with instability and aberrant intracellular processing of tyrosinase. Eur J Immunol (2012) 0.75
Single-domain VH antibody fragments from a phage display library. Methods Mol Biol (2003) 0.75
Exacerbation of pulmonary sarcoidosis after liver transplantation. J Clin Gastroenterol (2002) 0.75
[The burden and outcomes of acute bronchiolitis among young children hospitalized in Israel]. Harefuah (2009) 0.75
Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes. J Immunol (2002) 0.75